Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statements of Operations

v3.25.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Research and development $ 3,932,102 $ 2,985,118 $ 9,648,932 $ 4,643,693
Selling, general and administrative 5,164,433 5,903,673 10,391,546 12,555,296
Total operating expenses 9,096,535 8,888,791 20,040,478 17,198,989
Gain on sale of ENTADFI® assets 974,303 0 1,669,519 918,372
Operating loss from continuing operations (8,122,232) (8,888,791) (18,370,959) (16,280,617)
Non-operating income (expenses):        
Gain on extinguishment of debt 0 0 8,624,778 0
Change in fair value of equity securities 0 (192,030) (349,078) (571,928)
Other income, net 269,839 377,722 432,963 482,064
Total non-operating income (expenses) 269,839 185,692 8,708,663 (89,864)
Net loss from continuing operations (7,852,393) (8,703,099) (9,662,296) (16,370,481)
Net loss from discontinued operations, net of taxes (49,226) (1,322,849) (7,184,670) (1,931,448)
Net income (loss) $ (7,901,619) $ (10,025,948) $ (16,846,966) $ (18,301,929)
Net loss from continuing operations per basic and diluted common shares outstanding (in dollars per share) $ (0.05) $ (0.06) $ (0.07) $ (0.13)
Net loss from discontinued operations per basic and diluted common shares outstanding (in dollars per share) (0) (0.01) (0.05) (0.02)
Net loss per basic and diluted common shares outstanding (in dollars per share) $ (0.05) $ (0.07) $ (0.12) $ (0.15)
Basic and diluted weighted average common shares outstanding (in shares) 146,386,142 146,381,186 146,385,019 123,366,486